Naples, FL / ACCESS Newswire / March 18, 2026 / Stemtech Corporationthe global leader and pioneer in stem cell nutrition, is expanding Steamtech Bioscience E-commerce retail market channel in addition to the existing network marketing model.
(Stemtech Corporation – OTC:STEK)
“Live Long – Live Well – Live Young”
“We are redefining how global health is perceived, accessed and sustained while improving people’s quality of life. This is also in response to the growing demand for the natural mobilization of stem cells – it needs to be developed,” says John W. Meyer, President and COO of Stemtech.
In early 2026, Stemtech, a pioneer and global leader in stem cell nutrition, launched “Steamtech Revolution 2026″a transformative move that marks a bold new phase in the company 20 years old A history of leadership Cellular health. This initiative reflects Stemtech’s commitment to redefining preventive health and empowering individuals to improve long-term health at the cellular level.
At the heart of this strategic shift A multi-channel growth model Designed to maximize reach, impact and innovation:
1. The stem cell health revolution
In 2026, Stemtech strengthened its focus on functional, science-based wellness at the cellular level. With an emphasis on everyday cellular life, Stemtech has created a framework for sustainable, lasting wellness, expanded through the Stemtech Cellular Wellness movement.
2. Hybrid market strategy
SteamTech has been successfully implemented A hybrid market modelBoth operate:
MLM / Network Marketing Channel – Supporting independent business partners and promoting vibrant communities of prosperity.
Stemtech Bioscience’s direct-to-consumer retail channel – Expanding access to consumers interested in improving nutritional well-being and quality of life – Discovering the natural way and benefits of stem cell nutrition.
This dual channel approach has expanded market reach and engagement while maintaining strong governance, protecting the MLM network, and preventing brand dilution. Preliminary results show that retail initiatives increase brand awareness and build stronger relationships within the existing network.
3. Marketing and branding strategy developed
The StemTech Marketing Ecosystem now combines premium science branding with character-driven engagement, creating a presence that is:
Authentic – based on science, reliability, and expertise
Relevant – fun, engaging, and memorable
This strategy has differentiated Stemtech in the competitive nutrition landscape, building trust and community among consumers and partners.
The newly unveiled Stemtech Cellular Wellness Revolution 2026 logo symbolizes regeneration, scientific advancement, and a new commitment to longevity and human potential, while recognizing Stemtech’s history and marking the beginning of a new era of growth and impact.
“It’s more than a growth strategy – it’s a global movement that’s redefining how health is approached. Consistently implemented across products, digital platforms and educational content, Stemtech’s multi-channel growth strategy has laid the foundation for an already recognized global. Cellular Health Movementconnecting consumers, independent business partners and wellness enthusiasts around the world.” -Sandra Kaczykite, VP Global Operations
About Steamtech
Stemtech Corporation is a publicly traded healthcare company specializing in stemceuticals™ – All natural, plant-based nutritional solutions designed to support the body’s natural regenerative processes. Founded in 2018, after acquiring operations from StemTech International, Inc. (founded in 2005), the company has a long history of innovation in stem cell nutrition and health science.
From 2010 to 2015, Steamtech International, Inc., Inc. The list of 5000 fastest growing companies recognized four separate. In 2018, Steamtech underwent an extensive executive reorganization, and continued operations under new leadership as Steamtech Corporation. In August 2021, Steamtech became a publicly traded company (STEK) and expanded business opportunities for its Independent Business Partners (IBPs), who may earn income by sharing Steamtech products. Stemtech is positioned as a leader in stem cell nutrition, healing, skin care and soon animal health products, to increase sales in the wellness industry.
Stemtech’s comprehensive product portfolio reflects its dedication to optimal health. Our all natural innovations like stemrelease3™ (supports the body’s natural regenerative signaling pathways), StemFlow® Advanced (supports circulation and normal cellular communication and tissue support processes), MigraStem® (Supporting Healthy Aging and Longevity), and Aura Stem® Toothpaste (whitening teeth, freshening breath, anti-microbial, promoting good gum health) demonstrates the company’s unwavering commitment to quality-of-life products and natural influences. The latest launch of the Celica One® SHIELD: HOCL – a multi-purpose dust for skin care, cleansing and disinfection – and combined with Silic One® Stem Cell Rapid Renewal Peptide Night Cream (featuring patented QXP ingredients) highlights Stemtech’s pioneering edge in the beauty, health and wellness industry.
Stemtech introduces StemPets™ June 2025 – Nutritional supplement designed for both dogs and cats. Growing the global pet welfare market, currently valued at more than $303 billion annually, Stemtech is poised to transform pet health, with early adopters reporting significant improvements in health, energy, mood, and skin and coat quality for their four-legged family members.
For 20 years, Stemtech has not only championed the benefits of natural, plant-based ingredients but has also led the way in scientific innovation in the wellness, anti-aging and longevity sectors. As industry forecasts and studies from authoritative sources such as the World Institutes of Health Project Unprecedented Growth, Stemtech’s unwavering commitment to quality and innovation ensures they will remain at the forefront of this transformative journey that makes everyone healthier, while naturally slowing the aging process.
Visible Statements
This announcement contains forward-looking statements within the meaning of the “safe harbor” provisions of the US Private Securities Filing Reform Act of 1995. Such statements include, but are not limited to, those identified by words such as “belief,” “will,” “expectations,” “expectations,” “estimates,” “”” “estimates,” “distribution” statements. The statements in this release are based on the current beliefs and expectations of our company’s management and are subject to significant risks and uncertainties. Actual results may differ from those expressed in these forward-looking statements. Many factors could cause or contribute to such differences, including, but not limited to, the results of clinical trials and/or other studies, challenges in new product development initiatives, the impact of any competing products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future, changes in government policy and/or the potential review of our products and/or our potential government or regulatory review. actions, and other risks discussed from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update at any time any forward-looking statements contained in this press release or other public disclosures. Finally, the investing public is reminded that only announcements or information about Steamtech Corporation published by the company and bearing its name are considered official.
Contact for investor relations information:
CEO Charles S. Arnold Email: callcharlesarnold@gmail.com Phone: +1 336-918-0507
